Shanghai Shyndec Pharmaceutical Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Shanghai Shyndec Pharmaceutical has a total shareholder equity of CN¥15.2B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are CN¥20.1B and CN¥4.9B respectively. Shanghai Shyndec Pharmaceutical's EBIT is CN¥1.5B making its interest coverage ratio -12.5. It has cash and short-term investments of CN¥5.6B.
Informazioni chiave
7.1%
Rapporto debito/patrimonio netto
CN¥1.08b
Debito
| Indice di copertura degli interessi | -12.5x |
| Contanti | CN¥5.64b |
| Patrimonio netto | CN¥15.19b |
| Totale passività | CN¥4.87b |
| Totale attività | CN¥20.07b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Recent updates
Analisi della posizione finanziaria
Passività a breve termine: 600420's short term assets (CN¥11.6B) exceed its short term liabilities (CN¥4.6B).
Passività a lungo termine: 600420's short term assets (CN¥11.6B) exceed its long term liabilities (CN¥254.9M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 600420 has more cash than its total debt.
Riduzione del debito: 600420's debt to equity ratio has reduced from 46.9% to 7.1% over the past 5 years.
Copertura del debito: 600420's debt is well covered by operating cash flow (212.6%).
Copertura degli interessi: 600420 earns more interest than it pays, so coverage of interest payments is not a concern.